Navigation Links
Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Date:5/28/2009

SAN MATEO¿ Calif.¿ May 28 /PRNewswire/ -- Results and additional analyses from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at the Heart Failure Congress, the annual meeting of the Heart Failure Association of the European Society of Cardiology in Nice, France.

Marco Metra, M.D., professor of cardiology at the University of Brescia, Italy, and co-principal investigator of the Pre-RELAX-AHF study, will present the main results from the multicenter, international Pre-RELAX-AHF study at 8:30 a.m. CET on Sunday, May 31, at the Judges' Choice oral abstracts session. Dr. Metra will also present additional analyses of the Pre-RELAX-AHF study during a late-breaking clinical trials session at 11:15 a.m. CET on Monday, June 1. Five posters from the Pre-RELAX-AHF study will also be presented from 8:30 a.m. to 12:30 p.m. CET on Monday, June 1.

About Relaxin

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-pregnant women, including patients with heart failure.

About Corthera

Corthera Inc. is a private biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for acute heart failure. The company has worldwide rights to develop and commercialize relaxin. For more information, visit www.corthera.com. <
'/>"/>

SOURCE Corthera Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... , September 19, 2014 Reductions ... for many years in people with diabetes type 2 ... long term benefits for the kidneys." Australian ... with type 2 diabetes leads to persistent reductions in ... The global study has found that, five ...
(Date:9/18/2014)... Sept. 18, 2014  Low T Center endorses ... in Hyattsville, Maryland earlier ... the proper patient population for testosterone therapy (TRT), ... associated with TRT. Examining recent claims from studies that ... "available epidemiological studies do not provide convincing evidence ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... strengths of two institutions separated by nearly 9,000 miles over ... fight against cancer - the United States Agency for International ... Research Center to aid in the construction of the first ... is the first true collaboration between an African and a ...
... Oct. 26 Reportlinker.com announces that a new ... , Reportlinker Adds Outsourcing Preclinical Studies ... http://www.reportlinker.com/p0156558/Reportlinker-Adds-Outsourcing-Preclinical-Studies-to-China.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Within the past ... well as private and joint venture CRO,s have ...
Cached Medicine Technology:Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 2Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 3Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 4Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 5Hutchinson Center to Build First U.S. Cancer Clinic and Training Facility in Africa Thanks, in Part, to a Grant From USAID 6Reportlinker Adds Outsourcing Preclinical Studies to China 2Reportlinker Adds Outsourcing Preclinical Studies to China 3Reportlinker Adds Outsourcing Preclinical Studies to China 4Reportlinker Adds Outsourcing Preclinical Studies to China 5Reportlinker Adds Outsourcing Preclinical Studies to China 6
(Date:9/21/2014)... An experienced review website in the global market, ... and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and ... There has been a boom in websites in recent ... increase in the number of web hosting companies that ... prices. VPS (Virtual Private Server) is the method of ...
(Date:9/21/2014)... BambooIndustry.com, an experienced producer of natural bamboo items, has ... http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very popular ... discounted prices now, from 10 to 30 percent off. ... are available in many specifications; they are promised to ... finely manufactured by qualified workers. They are specially offered ...
(Date:9/21/2014)... September 21, 2014 Faculty and staff at ... coed preschool in Owings Mills, Md., kicked off the academic ... Vivofit bands. GFS is the first independent school to receive ... burned and even sleep patterns— as part of a pilot ... running and walking specialty chain. The Vivofit bands are just ...
(Date:9/21/2014)... According to latest National Vital Statistics Reports ... (10.5 births per 1,000 women in 2013). Since 2000, the ... by 2 percent per year. The birth rate for women ... over) also rose, the first such increase since 2008. Ultimately ... as many first births to women aged 35 and older ...
(Date:9/20/2014)... 21, 2014 Recently, iFitDress.com, a well-known wedding ... beautiful party dresses . In addition, the company has ... aim of the promotion is to benefit all of its ... its online store now. , Along with beautiful party ... items. It has recently released its new sexy short prom ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2
... college athletes who are on low-calorie diets could be ... Louis University research which was published in this month’s ... ,Researchers studied risk factors for exercise-related leg pain, including ... sports – cross-country running, field hockey, soccer and volleyball. ...
... teenage suicide and the antidepressant drug usage has been debatable. ... in kids and teens in most of the clinical trials ... ,In a recent study published in the September issue ... the Department of Psychiatry at Drexel University College of Medicine ...
... measures the amounts of two members of the same protein ... oncogene // , and the other as a tumor suppressor ... benefit from chemotherapy and those who won’t, according to researchers. ... and studies have shown that it can predict the aggressiveness ...
... nephrologists don't feel well prepared to make the decision ... end of life // , reports a study in ... Nephrology. ,Nephrologists who are more experienced and more ... by the Renal Physicians Association and the American Society ...
... Researchers said that a pill containing rhubarb extract could ... ,Researchers studied 109 perimenopausal women to determine ... women 4 milligrams of the extract, while the other ... which took the rhubarb extract pill, had less severe ...
... linked to increased incomes. Researchers said this demonstrated the ... social capital," said co-author Edward Stringham, an economics professor ... out networking, building relationships, and adding contacts to their ... said that the findings would be published in the ...
Cached Medicine News:Health News:Female Athletes at Risk of Stress Fractures 2Health News:Female Athletes at Risk of Stress Fractures 3Health News:Test Helps Identify Patients with Breast Cancer 2Health News:Many Kidney Specialists Feel Unprepared for End-of-Life Decisions 2
Clerz Plus helps retain moisture to relieve dryness and removes protein buildup from your lenses while you wear them for longer wear comfort....
Lens Plus rewetting drops for soft contact lenses....
... free lubricating and rewetting drops ... while you're wearing soft contact ... formula is ideal for eyes ... preservatives and for frequent users ...
... Renu Multiplus No Rub formula is the ... today. All steps in one bottle without ... stores soft contact lenses and removes protein ... multi-purpose solution that contains Hydranate, a special ...
Medicine Products: